AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $24,260,000 | +75.4% | 1,603,458 | -13.1% | 1.41% | +110.3% |
| Q2 2022 | $13,835,000 | -9.4% | 1,844,627 | +9.9% | 0.67% | +9.9% |
| Q1 2022 | $15,275,000 | +80.8% | 1,678,609 | +39.5% | 0.61% | +103.0% |
| Q4 2021 | $8,449,000 | -39.9% | 1,203,592 | -2.4% | 0.30% | -42.2% |
| Q3 2021 | $14,052,000 | -29.3% | 1,232,600 | -0.7% | 0.52% | -26.5% |
| Q2 2021 | $19,863,000 | -20.5% | 1,240,683 | -11.3% | 0.71% | -13.3% |
| Q1 2021 | $24,983,000 | +35.1% | 1,398,066 | +2.1% | 0.81% | +25.0% |
| Q4 2020 | $18,495,000 | +11.3% | 1,369,008 | -3.1% | 0.65% | -2.8% |
| Q3 2020 | $16,621,000 | -10.4% | 1,412,178 | +12.4% | 0.67% | -15.8% |
| Q2 2020 | $18,552,000 | +6.8% | 1,256,918 | -2.3% | 0.80% | -17.9% |
| Q1 2020 | $17,363,000 | -35.4% | 1,286,131 | +15.6% | 0.97% | +6.6% |
| Q4 2019 | $26,895,000 | +93.4% | 1,112,727 | +53.8% | 0.91% | +83.1% |
| Q3 2019 | $13,908,000 | -12.6% | 723,625 | +34.4% | 0.50% | -5.9% |
| Q2 2019 | $15,905,000 | -37.2% | 538,249 | +0.9% | 0.53% | -35.3% |
| Q1 2019 | $25,330,000 | +53.4% | 533,257 | +16.6% | 0.82% | +35.5% |
| Q4 2018 | $16,516,000 | -3.5% | 457,505 | +64.5% | 0.60% | -1.8% |
| Q3 2018 | $17,115,000 | -11.0% | 278,073 | -2.3% | 0.61% | -12.3% |
| Q2 2018 | $19,236,000 | +28.8% | 284,762 | +3.5% | 0.70% | +19.9% |
| Q1 2018 | $14,930,000 | -7.2% | 275,199 | +2.2% | 0.58% | -7.8% |
| Q4 2017 | $16,082,000 | +40.7% | 269,161 | +14.4% | 0.63% | +24.9% |
| Q3 2017 | $11,432,000 | -11.1% | 235,234 | -3.9% | 0.51% | -9.5% |
| Q2 2017 | $12,864,000 | +43.0% | 244,795 | +23.4% | 0.56% | +27.6% |
| Q1 2017 | $8,993,000 | +19.5% | 198,313 | -0.3% | 0.44% | +15.3% |
| Q4 2016 | $7,527,000 | +0.7% | 198,875 | +0.4% | 0.38% | -2.8% |
| Q3 2016 | $7,475,000 | +167.3% | 198,058 | +24.6% | 0.39% | +142.9% |
| Q2 2016 | $2,797,000 | +46.5% | 158,932 | +1.2% | 0.16% | +46.4% |
| Q1 2016 | $1,909,000 | -49.2% | 157,023 | +1.8% | 0.11% | -48.8% |
| Q4 2015 | $3,756,000 | +170.2% | 154,233 | +96.8% | 0.22% | +138.9% |
| Q3 2015 | $1,390,000 | – | 78,376 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|